OOIR: Observatory of International Research

Papers

(The TQCC of Seminars in Respiratory and Critical Care Medicine is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Monographic Issue on Pulmonary Hypertension: Medical and Interventional Treatment for Chronic Thromboembolic Pulmonary Hypertension	68
Improving Medication Adherence in Asthma	66
State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens	46
Sleep, Circadian Rhythms, and Lung Cancer	46
Impact of Digital Technologies on Clinical Care for Adults with Cystic Fibrosis	44
Severe Infections Due to Respiratory Viruses	38
Nonmalignant Pleural Effusions	35
Mechanical Ventilation for COVID-19 Patients	35
	34
Impact of Marijuana Use on Lung Health	30
Advances in the Understanding and Management of Chronic Obstructive Pulmonary Disease	22
Lung Transplant for Chronic Obstructive Pulmonary Disease	21
Imaging in the Intensive Care Unit	19
Chronic Obstructive Pulmonary Disease and Work: The Continuing Narrative	19
Prevention of Aspiration: Oral Care, Antibiotics, Others	19
Indwelling Pleural Catheter: Management of Complications	17
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection	16
Antibiotic Strategies for Severe Community-Acquired Pneumonia	15
	14
The Oral–Lung Microbiome Axis in Connective Tissue Disease-Related Interstitial Lung Disease	14
Any Role of High-Dose Vitamin C for Septic Shock in 2021?	14
Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis	14
COVID-19-Related Pleural Diseases	14
Chronic Pulmonary Aspergillosis: Clinical Presentation and Management	14
Deployment-Related Respiratory Disease: Where Are We?	14

	14
Pulmonary Physiology and Medicine of Diving	13
Management of Pulmonary Hypertension Associated with Chronic Lung Disease	12
Tissue Perfusion and Diffusion and Cellular Respiration: Transport and Utilization of Oxygen	12
Definition and Epidemiology of Sepsis	12
Update on Sepsis Epidemiology in the Era of COVID-19	12
Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease Overlap Syndrome	11
Nocturnal Hypoxemia in Respiratory Medicine: Pathophysiology, Measurement, and Association with Outcomes	11
Blood Gas Transport: Implications for O2 and CO2 Exchange in Lungs and Tissues	10
How to Survive Sepsis: Patient Testimonial	10
Work-Related Sleep Disorders: Causes and Impacts	10
Diagnostic Approach to Interstitial Lung Diseases Associated with Connective Tissue Diseases	10
Understanding the Updates in the Asthma Guidelines	10
Bronchoscopic Lung Volume Reduction: A Review	10
Methicillin-Resistant Staphylococcus aureus Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia	10
Beyond the Lungs—Emerging Challenges in Adult Cystic Fibrosis Care	10
Diagnosis and Management of Invasive Candida Infections in Critically Ill Patients	9
Community-Acquired Pneumonia: Postpandemic, Not Post-COVID-19	9
Survivorship Challenges and Supportive Care in Lung Cancer	9
Evidence for the Application of Sepsis Bundles in 2021	9
Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease	9
Malignant Central Airway Obstruction: What's New?	8
Comorbid Insomnia and Sleep Apnea: From Research to Clinical Practice	8
Management of Acutely Decompensated Pulmonary Hypertension	8
Interstitial Lung Disease Associated with Systemic Sclerosis	8
Pertussis Vaccination: The Challenges Ahead	8
Aspergillus and the Lung	7
Pathological Diagnosis of Pulmonary Aspergillosis	7
Life-Threatening Infections: Pulmonary and Systemic Infections	7
Pseudomonas aeruginosa Pneumonia: Evolution of Antimicrobial Resistance and Implications for Therapy	7
Severe Community-Acquired Pneumonia	7
Intra-abdominal Infections	7
Sleep and Circadian-Related Outcomes after Critical Illness	7
Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis	7
Severe Community-Acquired Pneumonia in Immunocompromised Patients	7
Clinical Features of COVID-19 and Differentiation from Other Causes of CAP	7
	7
Defining Clinical and Microbiological Nonresponse in Ventilator-Associated Pneumonia	7
“Long Haulers”	7
Arterial Blood Gases and Acid–Base Regulation	7
Pulmonary Hypertension Associated with Left Heart Disease	6
Precision Medicine to Guide Obstructive Sleep Apnea Treatment Beyond the Continuous Positive Airway Pressure	6
Viral Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia	6
Interventional Pulmonology and the Esophagus: Tracheostomy and Percutaneous Endoscopic Gastrostomy Placement	6
Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease	6
Cardiovascular Complications in Coronavirus Disease 2019—Pathogenesis and Management	6
HIV and COVID-19 Disease	6
Early Diagnosis of Sepsis: The Role of Biomarkers and Rapid Microbiological Tests	6
Intrapleural Anticancer Therapy for Malignant Pleural Diseases: Facts or Fiction?	6
Control of Breathing	6

Use of Antiviral Agents and other Therapies for COVID-19	6
Aspiration Pneumonia: Preface	6
Invasive Pulmonary Aspergillosis in Hospital and Ventilator-Associated Pneumonias	6
Advances in Disease-Modifying Therapeutics for Chronic Neuromuscular Disorders	6